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Abstract By consensus, the acyl-CoA synthetase (ACS) com-
munity, with the advice of the human and mouse ge-
nome nomenclature committees, has revised the nomencla-
ture for the mammalian long-chain acyl-CoA synthetases.
ACS is the family root name, and the human and mouse








, respectively. Splice variants of ACSL3, -4, -5, and
-6 are cataloged.  Suggestions for naming other family
members and for the nonmammalian acyl-CoA synthetases
are made.
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In mammals, long-chain acyl-CoA synthetase (ACSL)
catalyzes the initial step in cellular long-chain fatty acid
metabolism. In this reaction, ACSL ligates fatty acids to
































 AMP. Since the cDNA encoding ACSL
was cloned in 1990 (3), five isoforms of ACSL differing in
their substrate preferences, enzyme kinetics, cellular and
organelle locations, and regulation have been identified
and characterized in rodents and humans. Although our
knowledge of the ACSL family has advanced greatly in re-
cent years, inconsistencies regarding ACSL nomenclature
have led to confusion in the scientific literature. To allevi-
ate the confusion regarding ACSL naming and number-





coordination with the human and mouse genome nomen-
clature committees (HGNC and MGNC), have revised the
previous nomenclature system. The purpose of this report
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courage scientists referencing ACSL to adhere to the new
nomenclature.
NOMENCLATURE
The HGNC and MGNC have chosen ACS as the family
root name: synthetase, rather than ligase or synthase, was
selected for the activity and acyl-CoA for the product. Syn-
thetase refers to a reaction that uses ATP and forms an
acyl-AMP intermediate. Despite the fact that the best
known substrates are fatty acids, the entire spectrum of
natural and xenobiotic substrates used by ACSL and other
ACS subfamilies is not fully known, but it certainly encom-
passes substrates that are not fatty acids. For example, xe-
nobiotic carboxylic acids (4) and bile acids (5) are sub-
strates. Thus, the use of acyl-CoA is preferred because it
does not limit ACS substrates to fatty acids.
The ACS family includes enzymes that prefer short-,
medium-, long-, or very long-chain fatty acids as substrates.
Although related family members exhibit considerable
overlap in their use of fatty acids of similar chain lengths,
differences in the amino acid sequences of the AMP/ATP
and fatty acid binding motifs distinguish subfamilies previ-
ously designated as acetyl-CoA synthetase, medium-chain
acyl-CoA synthetase, long-chain acyl-CoA synthetase, very
long-chain acyl-CoA synthetase, bubblegum (lipidosin),
and scFat2p (6). Earlier studies used the term LACS (long-
chain ACS) to distinguish ACS isoforms that act on long-
chain fatty acids; however, the revised nomenclature rec-
ommends a hierarchical approach with ACS as the root
symbol followed by a letter to specify the length of fatty
acid acted upon. The HGNC and MGNC have approved
the ACSL mammalian gene nomenclature.
As standard guidelines for human and rodent gene no-













) and the rodent symbols are low-












) (7). The HGNC recommends that gene and al-
lele symbols be italicized and protein symbols be repre-
sented in nonitalicized fonts. Italics need not be used in
gene catalogs. Proteins are shown in uppercase letters. To
distinguish between mRNA, genomic DNA, and cDNA,


















, the first cloned human
ACSL family member, has caused considerable confusion.
Although two separate genes were originally reported to
encode FACL1 (fatty acid-CoA ligase) and FACL2 (8, 9), it









the same gene. Therefore, the revised nomenclature sys-






























 because it shares highest



























































Gene and Protein Sequences Gene and Protein Sequences





















































variant 1 / variant 2 / variant 3:
NM_016234 / NM_203379 / NM_203380














variant 1 / variant 2:
NM_015256 / AB020644
NP_056071 / BAA74860
variant 1 / variant 2:
NM_130739 / —
NP_570095 / AY625254
variant 1 / variant 2:
NM_144823 / AY167035
NP_659072 / AAO38689
This table is a modified version of that posted on the Human Genome Nomenclature Committee website (http://www.gene.ucl.ac.uk/nomenclature/
genefamily/acs.html). The final nomenclature for the other ACS subfamilies is still under consideration.
 






 (Table 1). Both transcripts encode the same
ACSL3 protein. Human ACSL3 is homologous to rat and
mouse ACSL3. Likewise, human ACSL4 is homologous to
rat and mouse ACSL4. In humans, two splice variants of








 contains an earlier in-frame start
codon that encodes a hydrophobic N terminus that is
41 amino acids longer. Human ACSL5, which is homolo-




 encodes a protein with a 56 amino acid longer
N terminus (ACSL5a) compared with the protein en-













 have been identified in humans and rodents (un-












 differ in amino acid residues
306–331 because they are encoded by exon 14 and exon
13, respectively, as a result of alternative exon use.




 genes encoding multi-
ple proteins having different N-terminal and/or internal
regions suggest that additional splice variants will be identi-














) if they use some of the same exons as an
existing ACSL isoform (http://www.gene.ucl.ac.uk/
nomenclature/guidelines.html). For genes with multiple
promoters, the alternative promoters are designated by the ad-





name: long-chain acyl-CoA synthetase 6, promoter 1). Proteins
translated from mRNA splice variants may be distinguished by
lowercase suffixes (e.g., ACSL5a and ACSL5b).
OTHER ACS FAMILY MEMBERS
It should be noted that proteins of the family previously
named very long-chain ACS (VLCS) (6) are also known as
fatty acid transport proteins (FATPs). These are included
in the superfamily of proteins encoded by members of the





 (12). The VLCS/FATPs also have
acyl-CoA synthetase enzymatic activity (13–16). Thus, these
proteins may play a dual role in the transport and esterifi-
cation of their substrates.
Some amino acid sequences are shared between ACSL
subfamily members and other enzymes, such as acetyl-CoA
synthetase, bubblegum, and scFat2p, and related proteins
(6). As yet, a standardized nomenclature has not been for-
mulated for these other enzymes or for the yeast and bacte-
rial ACS families. Each member of the extended ACS fam-
ily has the ATP/AMP binding motif that is a hallmark of
adenylate-forming enzymes as well as a fatty acid binding
motif defined in the bacterial homolog FadD (17).
CONCLUSIONS
Previous publications have used a multitude of names
for members of the ACSL family, which has led to confu-
sion among investigators. Implementation of the revised
nomenclature proposed here for the mammalian ACSL
gene family will reduce disparities and render our litera-
ture more accessible to us as well as to those outside the
field.








 root symbols for the acetyl-
CoA and medium-chain acyl-CoA synthetases, respectively,




and the bubblegum/lipidosin subfamily members use as
substrates long-chain and very long-chain fatty acids and/
or bile acids; thus, it is not yet clear what prefix should be
used to designate these enzymes. Further consultation is
needed among scientists who study these proteins. We
propose that those working on ACS genes in other organ-
isms also consider adopting a similar nomenclature.
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